Beate Haberle

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Radio-surgical decision-making in hepatoblastoma in the post-PHITT era: SIOPEL consensus recommendations.

Radio-surgical decision-making in hepatoblastoma in the post-PHITT era: SIOPEL consensus recommendations.

Journal: Seminars in pediatric surgery

Published: May 13, 2026

Preclinical Drug-Response Profiling Identifies BMI1 Inhibition as a Therapeutic Option for Hepatoblastoma.

Preclinical Drug-Response Profiling Identifies BMI1 Inhibition as a Therapeutic Option for Hepatoblastoma.

Journal: International journal of molecular sciences

Published: April 17, 2026

The landscape of pediatric hepatocellular carcinoma and fibrolamellar carcinoma: A report from the Children's Hepatic tumors International Collaboration (CHIC).

The landscape of pediatric hepatocellular carcinoma and fibrolamellar carcinoma: A report from the Children's Hepatic tumors International Collaboration (CHIC).

Journal: Cancer

Published: December 29, 2025

Airway infantile hemangiomas: Clinical characteristics and the potential role of ultrasound.

Airway infantile hemangiomas: Clinical characteristics and the potential role of ultrasound.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: September 18, 2025

Does Chemotherapy Have an Effect on the Treatment Success of Children and Adolescents with Unresectable Hepatocellular Carcinoma? Findings from the German Liver Tumour Registry.

Does Chemotherapy Have an Effect on the Treatment Success of Children and Adolescents with Unresectable Hepatocellular Carcinoma? Findings from the German Liver Tumour Registry.

Journal: Cancers

Published: July 02, 2025

Combining Reversible Electroporation and Bleomycin in Treatment of Arteriovenous Malformations.

Combining Reversible Electroporation and Bleomycin in Treatment of Arteriovenous Malformations.

Journal: Cardiovascular and interventional radiology

Published: June 02, 2025

Mechanistic models position ceritinib as a nuclear integrity disrupting therapy in pediatric liver tumors.

Mechanistic models position ceritinib as a nuclear integrity disrupting therapy in pediatric liver tumors.

Journal: Journal of experimental & clinical cancer research : CR

Published: May 28, 2025

Safety and Clinical Outcome of Bleomycin-Electrosclerotherapy (BEST) Treating Lymphatic Malformations (LMs).

Safety and Clinical Outcome of Bleomycin-Electrosclerotherapy (BEST) Treating Lymphatic Malformations (LMs).

Journal: Cardiovascular and interventional radiology

Published: May 11, 2025

Bleomycin Electrosclerotherapy (BEST) of Slow-Flow Vascular Malformations (SFVMs) in Children.

Bleomycin Electrosclerotherapy (BEST) of Slow-Flow Vascular Malformations (SFVMs) in Children.

Journal: Journal of pediatric surgery

Published: April 17, 2025

Upfront or delayed surgery in resectable hepatoblastoma: analysis from the children's hepatic tumors international collaboration database.

Upfront or delayed surgery in resectable hepatoblastoma: analysis from the children's hepatic tumors international collaboration database.

Journal: EClinicalMedicine

Published: May 29, 2024

Extracranial Vascular Anomalies Driven by RAS/MAPK Variants: Spectrum and Genotype-Phenotype Correlations.

Extracranial Vascular Anomalies Driven by RAS/MAPK Variants: Spectrum and Genotype-Phenotype Correlations.

Journal: Journal of the American Heart Association

Published: April 02, 2024

Outcome of bleomycin electrosclerotherapy of slow-flow malformations in adults and children.

Outcome of bleomycin electrosclerotherapy of slow-flow malformations in adults and children.

Journal: European radiology

Published: January 11, 2024

Showing 1-12 of 55

Last Updated: 09/26/2026